JHJob J. Herrmann

Job J. Herrmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Job J. Herrmann has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Sandra Sanders-Van Wijk

    Department of Cardiology, Zuyderland Medical Center , Henri Dunantstraat 5, Heerlen, 6419 PC

    4 shared publications
  • Fabienne Beckers-Wesche

    Department of Cardiology, Maastricht University Medical Center , Maastricht

    3 shared publications
  • Hans-Peter Brunner-La Rocca

    Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands

    3 shared publications
  • Louise Bellersen

    Department of Cardiology, Radboud University Medical Centre , Geert Grooteplein 10, P.O. Box 9101, Nijmegen, 6525 GA

    3 shared publications
  • D H Frank Gommans

    Department of Cardiology, Radboud University Medical Centre , Geert Grooteplein 10, P.O. Box 9101, Nijmegen, 6525 GA

    2 shared publications
  • D.H. Frank Gommans

    Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands

    2 shared publications

Latest Publications

  • Open Access

    The effect of a change in fluid intake advice on outcomes in chronic heart failure: a prespecified subanalysis of the FRESH-UP study

    by Job J Herrmann, Hans-Peter Brunner-La Rocca, Lisette E H J M Baltussen, Fabienne Beckers-Wesche, Sebastiaan C A M Bekkers, Louise Bellersen, J W Martijn Van Eck, H Carlijne Hassing, Tiny Jaarsma, Gerard C M Linssen, et al.

    Background and Aims: The Fluid REStriction in Heart failure versus liberal fluid UPtake (FRESH-UP) study (NCT04551729) randomized patients with chronic heart failure (HF) to liberal fluid intake (LFI) vs fluid restriction (FR). Pre-trial fluid management may have impacted trial outcomes. Methods: The open-label FRESH-UP study randomized 504 patients with chronic HF to an advice of LFI or FR of 1500 ml/day. Primary outcome was the Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OSS) after 3 months adjusted for baseline. Key secondary outcome was thirst distress. Patient-reported fluid intake was assessed at Week 6. Safety outcomes included death and hospitalizations. For this subanalysis, participants were stratified according to pre-trial fluid management (FR or LFI). Results: Prior to randomization, 269 (53.4%) patients adhered to FR and 235 (46.6%) adhered to LFI. After 3 month follow-up, KCCQ-OSS was significantly different between groups (P = .035): in patients changing from pre-trial FR to LFI, KCCQ-OSS was 74.7 [95% confidence interval (CI) 71.2–78.3] compared to 70.2 (95% CI 66.3–74.2) in those with the reversed scenario. In the latter group, thirst distress increased the most. Patient-reported fluid intake was significantly higher in patients randomized to LFI when compared to FR (P = .019), regardless of pre-trial FR or LFI (1771 and 1757 ml, vs 1486 and 1464 ml, respectively). Safety outcomes did not differ. Conclusions: These analyses add understanding to the effects of fluid intake management in chronic HF and expose a signal of potential harm of FR in patients with pre-trial LFI and a potential benefit of LFI in patients with pre-trial FR. These results corroborate with the primary results and support that there is no need to routinely initiate or continue FR in stable patients with chronic HF.

  • Open Access

    A machine learning model to detect falls mimicking cardiac arrest-related collapse based on wrist-derived accelerometry: the DETECT-2 study

    by Roos Edgar, Kambiz Ebrahimkheil, Danny Meeuwsen, Maud C de Jong, Job J Herrmann, Alexander M Griffioen, Niels T B Scholte, Marc A Brouwer, Rypko J Beukema, Eelko Ronner, et al.

    Aims: In wearable-based automated cardiac arrest detection technology, photoplethysmography (PPG) is the most commonly used sensor to detect the absence of pulsations. To minimize false-positive cardiac arrest alerts, accelerometry signals are often used for the detection of ongoing movement. We conducted the DETECT-2 study to develop an accelerometer-based machine learning model for the detection of cardiac arrest-related collapse, which is often a first manifestation of cardiac arrest. Methods and results: Healthy volunteers simulated cardiac arrest-related collapses through sudden and soft falls without subsequent movement. Accelerometer signals were collected using the CardioWatch wristband; video recordings were made as a reference. An accelerometer-based gradient boosting model (GBM) for fall detection was trained (70%) and tested (30%). The primary endpoint was the sensitivity for the detection of falls; secondary endpoints were false-positive fall alerts. Nineteen participants performed 567 falls. In the training set (n =13; 388 falls), the sensitivity of the GBM was 99.2% (95% confidence interval [CI] 98–100%], with four false positives. In the test set (n = 6; 179 falls), sensitivity was 96.1% (95% CI 92–98%), with two false positives. For sudden falls (n = 120) and soft falls (n = 59), sensitivities were 100% (95% CI 96–100%) and 88.1% (95% CI 76–95%) in the test set (P < 0.001), respectively. Conclusion: Using accelerometry data from the CardioWatch, sudden and soft falls that mimic cardiac arrest-related collapse can be accurately detected. The next step in the development of automated cardiac arrest detection is the integration of accelerometer signals into the existing PPG-based model, with the aim of reducing false positives and increasing sensitivity in everyday use.

  • Fluid restriction in patients with heart failure: a systematic review

    by Job J Herrmann, Rachna van Berlo, Hans-Peter Brunner-La Rocca, Sandra Sanders-Van Wijk, D H Frank Gommans, Roland R J van Kimmenade

    Background: Fluid restriction is a commonly prescribed non-pharmacological intervention in the management of heart failure (HF). However, data on its efficacy and safety are scarce. Recent randomised clinical trial (RCT) data prompt reassessment of the available evidence. Methods: CINAHL, EMBASE, PubMed and the Cochrane Library were searched up to 1 May 2025. RCTs were included if adults with HF were randomised to fluid restriction in comparison to a liberal or unrestricted intake, less strict restriction or usual care. Outcomes of interest were mortality, HF hospitalisation, quality of life (QoL), thirst distress, New York Heart Association (NYHA) class and N-terminal pro-Brain Natriuretic Peptide (CRD42022292319). No meta-analysis was performed due to high heterogeneity of the included trials. Results: In total, four RCTs were included, comprising 682 randomised inpatient, recently discharged and stable outpatient patients (ranging from 46 to 504 patients per trial). Only one study had a low risk of bias. None of the four trials found a significant difference in mortality or HF hospitalisations. For QoL, the results are contradictory, but overall, there is no clear benefit for fluid restriction, but it resulted in more thirst distress. No significant differences in NYHA class or (NT-pro)BNP were observed. Conclusion: Studies on fluid restriction in patients with HF are scarce, and most of the available studies are at high risk of bias. Although power is lacking, there is no evidence indicating that fluid restriction affects mortality or HF hospitalisations, but there is a signal of harm in terms of thirst distress. Taken together, the current evidence does not support the routine use of fluid restriction in patients with HF.


  • Top Cited Papers

    Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial

    by Job J. Herrmann, Hans-Peter Brunner-La Rocca, Lisette E. H. J. M. Baltussen, Fabienne Beckers-Wesche, Sebastiaan C. A. M. Bekkers, Louise Bellersen, J. W. Martijn van Eck, H. Carlijne Hassing, Tiny Jaarsma, Gerard C. M. Linssen, et al.

    Fluid restriction is frequently recommended to patients with chronic heart failure, but randomized clinical trials assessing the effects of fluid restriction remain scarce. In this multicenter open-label trial, outpatients with chronic heart failure were randomized to receiving advice for liberal fluid intake versus receiving advice for fluid restriction, up to 1,500 ml per day of fluid intake. The primary outcome of the trial was health status after 3 months, as assessed by the Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OSS). Secondary outcomes included thirst distress and safety events. Among 504 randomized patients (67.3% male), the KCCQ-OSS after 3 months was 74.0 in the liberal fluid intake group versus 72.2 in the fluid restriction group, with a mean difference after adjustment for baseline scores of 2.17 (95% confidence interval −0.06 to 4.39; P = 0.06), indicating that the primary outcome was not met. Thirst distress was higher in the fluid restriction group and no differences were observed for safety events between the two groups. These findings question the benefit of fluid restriction in chronic heart failure. ClinicalTrials.gov registration: NCT04551729.


  • Open Access

    Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP Study

    by Job J. Herrmann, Fabienne Beckers-Wesche, Lisette E.H.J.M. Baltussen, Marjolein H.I. Verdijk, Louise Bellersen, Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Ron Pisters, Sandra Sanders-Van Wijk, Laura Rodwell, et al.


  • What Is the Effect of Obesity on the Natriuretic Peptide Pathway?

    by Job J. Herrmann, Roland R.J. van Kimmenade, D.H. Frank Gommans